Teicoplanin Labatec 200 mg, poudre pour solution injectable/pour perfusion - 200 mg Swissmedic Key 59765001 Registration Holder Labatec Pharma SA Name Teicoplanin Labatec 200 mg, poudre pour solution injectable/pour perfusion Date of registration 03.02.2010 Introduction of Sequence 03.02.2010 ATC-Classification Teicoplanin (J01XA02) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 08.01.90. Show package size 200 mg Index Therapeuticus (Swissmedic) 08.01.90. Description Swissmedic categorie. A SL Eintrag No Indication Information for professionals IP Consumer information Ex-factory-Price PR Deductible k.A. Consumer price PR Feedback FB GTIN 7680597650012 Medication Code Synthetika Pharmacode Disponibility
Composition Praeparatio cryodesiccata: teicoplaninum 200 mg, natrii chloridum corresp. natrium 9.44 mg, pro vitro. Packungsbestandteile Label Praeparatio cryodesiccata:
Galenic Form poudre pour solution injectable/pour perfusion Excipiens Active Agent Dose Teicoplanine 200 mg
Inactive agents Sodium Chloride
Source Data was imported : 05.03.2020
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
